Trade Names: | |
Synonyms: | |
Status: | Approved (2016) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | R03DX08 |
UNII: | 35A26E427H |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Interleukin-5 inhibitor | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Asthma | 4 | D001249 | ClinicalTrials |
Sinusitis | 3 | D012852 | ClinicalTrials |
Substance-Related Disorders | 3 | D019966 | ClinicalTrials |
Eosinophilic Esophagitis | 3 | D057765 | ClinicalTrials |
Bronchitis | 2 | D001991 | ClinicalTrials |
Hypereosinophilic Syndrome | 2 | D017681 | ClinicalTrials |
Loiasis | 2 | D008118 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL2107884 |
FDA SRS | 35A26E427H |
Guide to Pharmacology | 8091 |